idxx
IDXX509.130USD
-0.399-0.08%
종가 05/13, 16:00（ET）시세는 15분 지연됩니다
41.11B시가총액
46.30P/E TTM
자세한 내용은 IDEXX Laboratories Inc 회사
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
회사 정보
회사 코드IDXX
회사 이름IDEXX Laboratories Inc
상장일Jun 21, 1991
설립일1983
CEOMr. Andrew Emerson
직원 수11000
유형Ordinary Share
회계 연도 종료Jun 21
주소One Idexx Drive
도시WESTBROOK
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호04092-2041
전화12075560300
웹사이트https://www.idexx.com/
회사 코드IDXX
상장일Jun 21, 1991
설립일1983
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Brian P. Mckeon
Mr. Brian P. Mckeon
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
29.92K
+0.16%
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
2.40K
--
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Brian P. Mckeon
Mr. Brian P. Mckeon
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
29.92K
+0.16%
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
수익 분석
통화: USD업데이트 시간: Sun, Apr 6
통화: USD업데이트 시간: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
CAG Diagnostics recurring revenue
3.13B
80.29%
Reference laboratory diagnostic and consulting services
1.34B
34.28%
IDEXX VetLab consumables
1.30B
33.44%
Rapid assay products
359.75M
9.23%
CAG Diagnostics capital - instruments
312.62M
8.02%
Other
-2.54B
-65.27%
지역별USD
이름
수익
비율
United States
2.53B
64.99%
Other Euorpe
196.31M
5.04%
Germany
173.68M
4.46%
Canada
152.88M
3.92%
United Kingdom
134.63M
3.45%
Other
706.82M
18.14%
사업별
지역별
사업별USD
이름
수익
비율
CAG Diagnostics recurring revenue
3.13B
80.29%
Reference laboratory diagnostic and consulting services
1.34B
34.28%
IDEXX VetLab consumables
1.30B
33.44%
Rapid assay products
359.75M
9.23%
CAG Diagnostics capital - instruments
312.62M
8.02%
Other
-2.54B
-65.27%
주주
업데이트 시간: Sat, May 10
업데이트 시간: Sat, May 10
주주 통계
유형
주주 통계
주주
비율
The Vanguard Group, Inc.
12.12%
BlackRock Institutional Trust Company, N.A.
6.71%
State Street Global Advisors (US)
4.49%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
2.83%
Other
70.56%
주주 통계
주주
비율
The Vanguard Group, Inc.
12.12%
BlackRock Institutional Trust Company, N.A.
6.71%
State Street Global Advisors (US)
4.49%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
2.83%
Other
70.56%
유형
주주
비율
Investment Advisor/Hedge Fund
41.96%
Investment Advisor
41.81%
Research Firm
3.85%
Pension Fund
2.29%
Hedge Fund
2.24%
Bank and Trust
1.90%
Sovereign Wealth Fund
1.32%
Individual Investor
0.67%
Family Office
0.46%
Other
3.51%
기관 주식 보유
업데이트 시간: Sun, Jan 19
업데이트 시간: Sun, Jan 19
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
2230
77.53M
95.67%
-2.91M
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
2023Q1
2158
77.14M
92.96%
-2.07M
2022Q4
2124
77.44M
93.49%
-2.66M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
9.67M
11.94%
-29.32K
-0.30%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
5.32M
6.57%
-239.97K
-4.31%
Dec 31, 2024
State Street Global Advisors (US)
3.64M
4.49%
+24.20K
+0.67%
Dec 31, 2024
Fundsmith LLP
2.66M
3.29%
-1.31K
-0.05%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.30M
2.83%
+37.73K
+1.67%
Dec 31, 2024
Baron Capital Management, Inc.
2.01M
2.47%
+82.26K
+4.28%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
1.69M
2.09%
+22.74K
+1.36%
Feb 28, 2025
AllianceBernstein L.P.
1.24M
1.53%
-1.58M
-56.02%
Dec 31, 2024
BlackRock Asset Management Ireland Limited
1.13M
1.39%
+36.40K
+3.33%
Dec 31, 2024
Principal Global Investors (Equity)
711.20K
0.88%
-19.27K
-2.64%
Dec 31, 2024
더 보기
관련 ETF
업데이트 시간: Fri, May 2
업데이트 시간: Fri, May 2
이름
비율
ProShares Pet Care ETF
9.82%
First Trust Water ETF
3.82%
iShares U.S. Medical Devices ETF
3.79%
Inspire Tactical Balanced ETF
2.66%
First Trust S&P 500 Economic Moat Index ETF
1.91%
American Century Mid Cap Growth Impact ETF
1.83%
Putnam Sustainable Future ETF
1.8%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
1.7%
Tema Monopolies and Oligopolies ETF
1.59%
Invesco S&P 500 Equal Weight Health Care ETF
1.57%
더 보기
ProShares Pet Care ETF
비율9.82%
First Trust Water ETF
비율3.82%
iShares U.S. Medical Devices ETF
비율3.79%
Inspire Tactical Balanced ETF
비율2.66%
First Trust S&P 500 Economic Moat Index ETF
비율1.91%
American Century Mid Cap Growth Impact ETF
비율1.83%
Putnam Sustainable Future ETF
비율1.8%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
비율1.7%
Tema Monopolies and Oligopolies ETF
비율1.59%
Invesco S&P 500 Equal Weight Health Care ETF
비율1.57%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음